Donna L. Mapes, DNSc, Jennifer L

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Organ Trafficking: Global Solutions for a Global Problem

Renal Function Testing

Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.

Volume 70, Issue 8, Pages (October 2006)

Peritoneal dialysis American Journal of Kidney Diseases

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Metabolic Complications in Elderly Adults With CKD

Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes Hon-Yen Wu, MD, PhD, Shingo Fukuma, MD, PhD,

Care of the Undocumented Immigrant in the United States With ESRD

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD

A Decade After the KDOQI CKD Guidelines

Cardiovascular Disease and CKD: Core Curriculum 2010

The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective Gregorio T. Obrador, MD, MPH, Ximena Rubilar,

Recognition for Conservative Care in Kidney Failure

CKD and Poverty: A Growing Global Challenge

Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Glycemic Management in ESRD and Earlier Stages of CKD

Salt and Hypertension American Journal of Kidney Diseases

Karl D. Nolph, MD, American Journal of Kidney Diseases

Greg A. Knoll, MD, MSc American Journal of Kidney Diseases

Volume 63, Issue 3, Pages (March 2003)

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

Dorothea Nitsch, MD, MSc American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

Iain C. Macdougall, MD American Journal of Kidney Diseases

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Julie A. Wright Nunes, MD, MPH, Kerri L

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

CPR 1.2.: Evaluation of Anemia in CKD

Volume 64, Issue 5, Pages (November 2003)

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Organ Trafficking: Global Solutions for a Global Problem

Study Designs in Patient-Oriented Research

Dennis G. Moledina, MD, Mark A. Perazella, MD

Volume 66, Issue 5, Pages (November 2004)

Volume 70, Issue 10, Pages (November 2006)

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States George A. Kaysen, MD, PhD, Kirsten.

Risk for Incident Renal Dialysis in a Managed Care Population

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Volume 64, Issue 1, Pages (July 2003)

David A. Goodkin, MD, Eric W

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Volume 68, Issue 1, Pages (July 2005)

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

In the Literature: Cognitive Impairment in Hemodialysis Patients

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

American Journal of Kidney Diseases

Role of glucocorticoids in acidosis

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Presentation transcript:

Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Donna L. Mapes, DNSc, Jennifer L. Bragg-Gresham, MS, Jürgen Bommer, MD, Shunichi Fukuhara, MD, MSc, Patricia McKevitt, MSW, Björn Wikström, MD, Antonio Alberto Lopes, MD, PhD American Journal of Kidney Diseases Volume 44, Pages 54-60 (November 2004) DOI: 10.1053/j.ajkd.2004.08.012 Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Adjusted relative risks of death and first hospitalization by quintile of scores for HRQOL component summary scores. Relative risks of death (■) and first hospitalization (▵) by quintile of scores for each component of HRQOL, adjusted for demographic factors and comorbid conditions, including albumin, stratified by country and diabetes. The highest quintile is used as the reference group. For all 6 lines, there was a statistically significant trend (each P < 0.001) in the risks of both outcomes to increase.6 Reprinted from Mapes et al6 with the permission of Blackwell Publishing. © 2003 by the International Society of Nephrology. American Journal of Kidney Diseases 2004 44, 54-60DOI: (10.1053/j.ajkd.2004.08.012) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Adjusted relative risk of death (A) and first hospitalization (B) according to level of depression assessed by the following questions: (1) How much of time have you felt so down in the dumps that nothing could cheer you up? (■) and (2) How much of the time have you felt downhearted and blue? (▵). “None of the time” is the referent (Ref) group. The dotted lines represent the RR expected under the null hypothesis (RR = 1). The models were adjusted for years on dialysis, sociodemographic factors, laboratory variables, and comorbid indicators. Statistically significant RRs (P < 0.05) are identified with an asterisk.10 Reprinted from Lopes et al10 with the permission of Blackwell Publishing. © 2002 by the International Society of Nephrology. American Journal of Kidney Diseases 2004 44, 54-60DOI: (10.1053/j.ajkd.2004.08.012) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions